The direct effects of tacrolimus and cyclosporin A on isolated human islets A functional, survival and gene expression study

被引:30
作者
Bugliani, Marco [1 ]
Masini, Matilde [1 ]
Liechti, Robin [2 ]
Marselli, Lorella [1 ]
Xenarios, Ioannis [2 ]
Boggi, Ugo [1 ]
Filipponi, Franco [1 ]
Masiello, Pellegrino [1 ]
Marchetti, Piero [1 ]
机构
[1] Univ Pisa, Dept Endocrinol & Metab, Pisa, Italy
[2] Swiss Inst Bioinformat, Vital IT, Lausanne, Switzerland
关键词
pancreatic islets; tacrolimus; cyclosporin A; beta-cell apoptosis; microarray; ONSET DIABETES-MELLITUS; PANCREATIC-ISLETS; IMMUNOSUPPRESSIVE AGENTS; INSULIN-SECRETION; TRANSPLANTATION; CELL; INHIBITION; MANAGEMENT; DEFECTS; RELEASE;
D O I
10.4161/isl.1.2.9142
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
The use of immunosuppressive drugs in transplanted patients is associated with the development of diabetes, possibly due to beta-cell toxicity. To better understand the mechanisms leading to post-transplant diabetes, we investigated the actions of prolonged exposure of isolated human islets to therapeutical levels of tacrolimus (Tac) or cyclosporin A (CsA). Islets were isolated from the pancreas of multiorgan donors by enzymatic digestion and density gradient centrifugation. Functional, survival and molecular studies were then performed after four days of incubation with therapeutical concentrations of Tac or CsA. Glucose-induced insulin secretion was significantly decreased in Tac, but not in CsA exposed islets, which was associated with a reduction of the amount of insulin granules as shown by electron microscopy. The percentage of apoptotic beta-cells was higher in Tac than CsA exposed islets. Microarray experiments followed by Gene Set Enrichment Analysis revealed that gene expression was more markedly affected upon Tac treatment. In conclusion, Tac and CsA affect features of beta-cell differently, with several changes occurring at the molecular level.
引用
收藏
页码:106 / 110
页数:5
相关论文
共 32 条
[1]
Functional and morphological study of cultured pancreatic islets treated with cyclosporine [J].
Ajabnoor, Mohammad A. ;
El-Naggar, Mostafa M. ;
Elayat, Ahmed A. ;
Abdulrafee, Adel .
LIFE SCIENCES, 2007, 80 (04) :345-355
[2]
New-onset diabetes mellitus in the kidney recipient: Diagnosis and management strategies [J].
Bloom, Roy D. ;
Crutchlow, Michael F. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 :S38-S48
[3]
Functional and molecular defects of pancreatic islets in human type 2 diabetes [J].
Del Guerra, S ;
Lupi, R ;
Marselli, L ;
Masini, M ;
Bugliani, M ;
Sbrana, S ;
Torri, S ;
Pollera, M ;
Boggi, U ;
Mosca, F ;
Del Prato, S ;
Marchetti, P .
DIABETES, 2005, 54 (03) :727-735
[4]
Islet cell damage associated with tacrolimus and cyclosporine: Morphological features in pancreas allograft biopsies and clinical correlation [J].
Drachenberg, CB ;
Klassen, DK ;
Weir, MR ;
Wiland, A ;
Fink, JC ;
Bartlett, ST ;
Cangro, CB ;
Blahut, S ;
Papadimitriou, JC .
TRANSPLANTATION, 1999, 68 (03) :396-402
[5]
Using GOstats to test gene lists for GO term association [J].
Falcon, S. ;
Gentleman, R. .
BIOINFORMATICS, 2007, 23 (02) :257-258
[6]
affy -: analysis of Affymetrix GeneChip data at the probe level [J].
Gautier, L ;
Cope, L ;
Bolstad, BM ;
Irizarry, RA .
BIOINFORMATICS, 2004, 20 (03) :307-315
[7]
A 6-year prospective study on new onset diabetes mellitus, insulin release and insulin sensitivity in renal transplant recipients [J].
Hagen, M ;
Hjelmesæth, J ;
Jenssen, T ;
Morkrid, L ;
Hartmann, A .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (10) :2154-2159
[8]
REVERSIBILITY OF THE ACUTE TOXIC EFFECT OF CYCLOSPORINE-A ON PANCREATIC B-CELLS OF WISTAR RATS [J].
HAHN, HJ ;
DUNGER, A ;
LAUBE, F ;
BESCH, W ;
RADLOFF, E ;
KAUERT, C ;
KOTZKE, G .
DIABETOLOGIA, 1986, 29 (08) :489-494
[9]
TOXIC EFFECTS OF CYCLOSPORINE ON THE ENDOCRINE PANCREAS OF WISTAR RATS [J].
HAHN, HJ ;
LAUBE, F ;
LUCKE, S ;
KLOTING, I ;
KOHNERT, KD ;
WARZOCK, R .
TRANSPLANTATION, 1986, 41 (01) :44-47
[10]
Quality assessment of affymetrix GeneChip data [J].
Heber, Steffen ;
Sick, Beate .
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2006, 10 (03) :358-368